VRAX short interest
Virax Biolabs Group Limited · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,645 |
|---|---|
| Change vs prior report | -23,871 (-78.2%) |
| Change over six months | +3049.3% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 30,903 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
VRAX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,645 | -78.2% | 1.00 | 30,903 |
| 2026-09-15 | 30,516 | +52.7% | 1.00 | 39,174 |
| 2026-08-31 | 19,982 | -14.4% | 1.00 | 1,681,965 |
| 2026-08-14 | 23,357 | -25.8% | 1.00 | 103,173 |
| 2026-07-31 | 31,482 | +25.7% | 1.00 | 1,113,775 |
| 2026-07-15 | 25,046 | -58.7% | 1.00 | 7,378,977 |
| 2026-06-30 | 60,615 | -94.1% | 1.00 | 137,557 |
| 2026-06-15 | 1,024,533 | -4.2% | 1.00 | 5,323,619 |
| 2026-05-29 | 1,068,991 | +173.2% | 1.00 | 110,754,674 |
| 2026-05-15 | 391,277 | +173.2% | 1.00 | 5,873,723 |
| 2026-04-30 | 143,206 | -97.1% | 1.00 | 2,702,976 |
| 2026-04-15 | 5,006,970 | +2372871.6% | 1.00 | 51,096,171 |
| 2026-03-31 | 211 | -98.0% | 1.00 | 19,621,040 |
| 2026-03-13 | 10,571 | -81.0% | 1.00 | 193,015 |
| 2026-02-27 | 55,704 | +163.7% | 1.00 | 224,823 |
| 2026-02-13 | 21,126 | -67.6% | 1.00 | 155,980 |
| 2026-01-30 | 65,207 | +11.3% | 1.00 | 251,600 |
| 2026-01-15 | 58,591 | -38.7% | 1.00 | 352,079 |
| 2025-12-31 | 95,551 | -36.3% | 1.00 | 547,804 |
| 2025-12-15 | 149,941 | +639.2% | 1.00 | 27,512,123 |
| 2025-11-28 | 20,284 | -5.8% | 1.00 | 85,783 |
| 2025-11-14 | 21,529 | -51.3% | 1.00 | 148,628 |
| 2025-10-31 | 44,175 | +182.7% | 1.00 | 280,296 |
| 2025-10-15 | 15,626 | -64.5% | 1.00 | 163,768 |
| 2025-09-30 | 44,012 | -68.5% | 1.00 | 460,978 |
import finzdata as yf
yf.Ticker("VRAX").short_interest # every report since 2017
yf.Client().short_interest(["VRAX"], start="2018-01-01")Healthcare short interest · VRAX price history · Who owns VRAX · All short interest